ENVERIC BIOSCIENCES, INC. – Trademark Portfolio
Entity Type: 03
ENVERIC BIOSCIENCES, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ENVERIC, ENVERIC BIOSCIENCES, and NEXT GENERATION MENTAL HEALTH. The owner is based in NAPLES, FL.
4851 TAMIAMI TRAIL N
SUITE 200
NAPLES, FL 34103
Showing of trademarks Trademarks
Trademark Classifications
ENVERIC BIOSCIENCES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ENVERIC BIOSCIENCES, INC. have?
ENVERIC BIOSCIENCES, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.
What trademark classes does ENVERIC BIOSCIENCES, INC. file in?
ENVERIC BIOSCIENCES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ENVERIC BIOSCIENCES, INC.'s most well-known trademarks?
ENVERIC BIOSCIENCES, INC.'s registered trademark portfolio includes well-known marks such as ENVERIC, ENVERIC BIOSCIENCES, and NEXT GENERATION MENTAL HEALTH. These are among 4 currently registered trademarks in the portfolio.
What is ENVERIC BIOSCIENCES, INC.'s trademark registration success rate?
ENVERIC BIOSCIENCES, INC. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.